Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies

Trends in Molecular Medicine(2021)10.1016/j.molmed.2021.06.013Source: DataRank Database

Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies is a research paper published in Trends in Molecular Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (15)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Daichi Inoue ORCID,Lingbo Zhang ORCID,Gaurang Trivedi ORCID

Live enrichment

PubMed:34257007 PMC:PMC8487963

National Heart, Lung, and Blood Institute

Grant: U01 HL127522

National Institutes of Health

Grant: 5U01HL127522-03

Establishing a Long Island Bioscience Hub

Edward P. Evans Foundation

National Institutes of Health

Cold Spring Harbor Laboratory

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8487963

publisherhttps://api.elsevier.com/content/article/PII:S1471491421001805?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1471491421001805?httpAccept=text/plain

https://doi.org/10.1016/j.molmed.2021.06.013

https://pubmed.ncbi.nlm.nih.gov/34257007

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansAnemiaMyelodysplastic Syndromes

Keywords

Myelodysplastic syndromeErythropoiesis-stimulating AgentsBurst Forming Unit-erythroidSplicing ModulationCholinergic Receptor Muscarinic 4Hematopoietic ArcMyelodysplastic SyndromesHumansAnemia

Sustainable Development Goals

SDG 3: 3. Good health

Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies

FAIR Checklist

Authors (3)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)